Inogen (INGN) Net Income towards Common Stockholders Growth (1y) (2014 - 2026)
Powered by 
Analysis
Inogen (INGN) Net Income towards Common Stockholders Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -47.84% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 23.94% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 41.36% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 44.34% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 13.80% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -27.18% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 38.54% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 12.92% |
| 10 | Inogen | 142.58 Mn | 37.04 Mn | 43.27 Mn | 22.53% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.53% |
| Mar 31, 2026 | -31.39% |
| Dec 31, 2025 | 64.86% |
| Sep 30, 2025 | 0.29% |
| Jun 30, 2025 | 14.88% |
| Mar 31, 2025 | 56.74% |
| Dec 31, 2024 | 63.60% |
| Sep 30, 2024 | 86.95% |
| Jun 30, 2024 | 43.11% |
| Mar 31, 2024 | 28.36% |
| Dec 31, 2023 | 52.96% |
| Sep 30, 2023 | -380.81% |
| Jun 30, 2023 | -246.47% |
| Mar 31, 2023 | -47.89% |
| Dec 31, 2022 | -152.54% |
| Sep 30, 2022 | -177.41% |
| Jun 30, 2022 | -157.06% |
| Mar 31, 2022 | -1,314.18% |
| Dec 31, 2021 | -340.60% |
| Sep 30, 2021 | 822.78% |